1. Evidence of CD4 + regulatory T cells in the non-obese diabetic male mouse

   • P. Sempé
   • M. -F. Richard
   • C. Boitard

   Originals Pages: 337 - 343

2. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM

   • C. E. Grubin
   • T. Daniels
   • Å. Lernmark

   Originals Pages: 344 - 350

3. Irreversible loss of normal beta-cell regulation by glucose in neonatally streptozotocin diabetic rats

   • K. Inoue
   • M. Cetkovic-Cvrlje
   • V. Grill

   Originals Pages: 351 - 357

4. Decreased protein catabolism after exercise in subjects with IDDM

   • J. T. Devlin
   • A. Scrimgeour
   • S. Fuller

   Originals Pages: 358 - 364

5. Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease

   • R. Wagner
   • S. Genovese
   • E. A. M. Gale

   Originals Pages: 365 - 371

6. Mitochondrial gene defects in patients with NIDDM

   • J. C. Alcolado
   • A. Majid
   • A. H. Barnett

   Originals Pages: 372 - 376

7. Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects

   • G. Sindelka
   • L. Heinemann
   • E. Chantelau

   Originals Pages: 377 - 380

8. Diet, cow's milk protein antibodies and the risk of IDDM in Finnish children

   • S. M. Virtanen
   • T. Saukkonen
   • P. Varimo

   Originals Pages: 381 - 387

9. Natural history of preclinical IDDM in high risk siblings

   • M. Knip
   • P. Vähäsalo
   • S. M. Virtanen

   Originals Pages: 388 - 393

10. Erythrocyte sodium-lithium countertransport activity is related to membrane fluidity in IDDM patients

    • A. Dowd
    • T. H. Thomas
    • R. Wilkinson

    Originals Pages: 394 - 400

11. Effect of insulin on GLUT-4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives

    • C. Schalin-Jäntti
    • H. Yki-Järvinen
    • L. C. Groop

    Originals Pages: 401 - 407

12. Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH_4–9 analogue ORG 2766 in IDDM patients with neuropathy

    • B. Bravenboer
    • P. H. Hendrikse
    • D. W. Erkelens

    Originals Pages: 408 - 413

13. Valid parameters for investigation of the pupillary light reflex in normal and diabetic subjects shown by factor analysis and partial correlation

    • R. H. Straub
    • U. Thies
    • J. Schölmerich

    Originals Pages: 414 - 419

14. Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients

    • Y. Tanizawa
    • A. C. Riggs
    • M. A. Permutt

    Originals Pages: 420 - 427

15. Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta₂-adrenoceptors

    • S. Reynisdottir
    • H. Wahrenberg
    • P. Arner

    Originals Pages: 428 - 435

16. Amylin tonally regulates arginine-stimulated insulin secretion in rats

    • W. M. Bennet
    • C. S. Beis
    • S. R. Bloom

    Rapid Communication Pages: 436 - 438

17. Effect of insulin-like growth factor-1 therapy on erythropoetin concentrations in extreme insulin resistance

    • J. D. Quin
    • J. P. Miell
    • A. C. MacCuish

    Letters to the Editor Pages: 439 - 439

18. d-Lysine and non-enzymatic glycation

    • A. Ceriello
    • M. Sensi

    Letters to the Editor Pages: 440 - 440

19. Impact of glycaemic control on urinary albumin excretion in patients with Type 2 (non-insulin- dependent) diabetes mellitus

    • C. Carlberg
    • P. -M. Schumm-Draeger
    • E. Jungmann

    Letters to the Editor Pages: 441 - 441

20. Is glucokinase the beta-cell glucoreceptor?

    • W. J. Malaisse

    Letters to the Editor Pages: 442 - 442